TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Hematologic Malignancy · Non Hodgkin Lymphoma · Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia, Adult · Myelodysplastic Syndromes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Jianxiang Wang, MD) · wangjx@ihcams.ac.cn · +86-022-23909120

Study leads

Jianxiang Wang, MD
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, China
Bo Jiang, MD
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Brain Cancer · Breast Cancer · Bladder Cancer

Abroad (travel likely)Recruiting

Duarte, United States · Miami, United States

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT

Myeloid Leukemia · Myelodysplastic Syndromes

Abroad (travel likely)RecruitingPHASE2

Beijing, China

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

Acute Lymphoblastic Leukemia · Leukemia · Non-Hodgkin's Lymphoma

Abroad (travel likely)Recruiting

Graz, Austria · Leoben, Austria